E10i-494
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
MeTis Lipid 5 is an ionizable lipid featuring a pyrazole-based headgroup and biodegradable C8-ester twin tails developed by MeTis Pharmaceuticals (Patent CN118290339B). It demonstrated breakthrough in vivo efficacy (7.08E+10 photons, luciferase assay), surpassing MC3 lipid by 8.8-fold in systemic mRNA delivery. The molecule achieves optimal safety-profile (96.4% cell viability) and encapsulation efficiency (96.4%), forming LNPs of 108.9 nm (PDI 0.17) at N/P 6. Its ester-enabled rapid metabolization and balanced hydrophobicity position lipid 5 as a candidate for next-gen mRNA therapeutics.
| CAS No. | Not available |
| Chemical Name | MeTis Lipid 5 |
| Synonyms | MeTis Lipid-5 |
| SMILES | CCCCCCC(CCCCCC)CN1C=C(C(=O)OCCCCCCN(CCCCO)CCCCCCOC(=O)C2=CN(CC(CCCCCC)CCCCCC)N=C2)C=N1 |
| Formula | C45H89NO5 |
| M.Wt | 870.36 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 11.4895 mL | 2.2979 mL | 1.1489 mL |
| 25 mg | 28.7237 mL | 5.7447 mL | 2.8724 mL |
| 50 mg | 57.4475 mL | 11.4895 mL | 5.7447 mL |
| 100 mg | 114.8950 mL | 22.9790 mL | 11.4895 mL |
| 250 mg | 287.2375 mL | 57.4475 mL | 28.7237 mL |
Contact our team with the catalog number and requested quantity.